ITB Therapy^SM And Cerebral Palsy

Nick, living with CP. Receiving ITB Therapy since 1999.

It is estimated that 70-80% people with cerebral palsy experience spasticity.²² Managing cerebral-origin spasticity with Medtronic ITB Therapy (Intrathecal Baclofen Therapy):

• May facilitate spinal stabilization by decreasing asymmetrical tone²³
• Does not interfere with future corrective surgery for scoliosis²³
• Results in improved function^25,31
• Reduces muscle tone, which may slow or prevent the development of hip subluxation and dislocation²⁶
• Helps facilitate improvements in self-care and social function²⁷
• May delay or avoid orthopedic or neurologic surgery²³
• Shows a positive impact on functional measures and ease of care^12,18,27
• Shows a positive impact on quality of life^29,30,31
• Facilitates care and comfort¹²
• Decreases caregiver burden³¹
• Decreases pain associated with spasticity^12,18,31,35
• Is unlikely to impact fixed deformities²⁴

See the Clinical Evidence in Hypertonia Associated with CP section for more information on some of these studies and their outcomes.

©Medtronic, Inc. 2008                                                   • Contact Medtronic • Privacy Statement • Terms of Use • Site Map